Today we give you our conversation with Drs. Jennifer Puig and Lisa Drozdick on the update to the Advanced Clinical Solutions, including the Test of Premorbid Functioning, 2nd Edition, which are scheduled for release sometime in 2026. We previously spoke with Jenn and Lisa about the WMS-5, with the episode released on November 1st. We have no financial or other relationship with Pearson and The INS neither promotes nor recommends any commercial products or services discussed in this episode.
About Jenn
Jennifer Puig, Ph.D., LP is a Research Director for Pearson Clinical Assessment’s Healthcare and Therapeutics product line. She is a licensed clinical psychologist, pediatric neuropsychologist, and researcher. She received her PhD in Child Psychology from the Institute of Child Development. She completed her pre-doctoral internship and post-doctoral fellowship in pediatric neuropsychology and the University of Minnesota Medical Center. She currently works on the development of neuropsychological and cognitive measures across the lifespan. Jennifer has worked on tests measuring memory and executive function.
About Lisa
Lisa Whipple Drozdick, PhD, is a licensed clinical psychologist, researcher, and published author. She received her clinical training at West Virginia University and the South Texas Veterans Healthcare System. She currently manages the Healthcare and Therapeutics R&D team at Pearson and leads the development of neuropsychological and cognitive measures across the lifespan. Lisa has led the development efforts on products assessing memory, executive functioning, cognitive ability, adaptive functioning, and behavior. She is a member of the National Academy of Neuropsychology, International Neuropsychological Society, and American Psychological Association (Divisions 12 Section 2, 20, 22, 40).